Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2004 08:21 ET | Source: Diamyd Medical

Diamyd starts larger trial in type 2 diabetes patients in Sweden

STOCKHOLM, Sweden, Oct. 7, 2004 (PRIMEZONE) -- At the International Diabetes Federation meeting in Los Angeles, USA, it will be announced today that a larger clinical trial with Diamyd will start in...
June 14, 2004 11:15 ET | Source: Diamyd Medical

20MUSD to Diamyd Medical through new stock emission

STOCKHOLM, Sweden, June 14, 2004 (PRIMEZONE) -- Diamyd Medical's preferential rights issue in May of up to 2 318 189 B- shares has been oversubscribed by 70%. The Board has therefore decided, in...
June 10, 2004 10:51 ET | Source: Diamyd Medical

Diabetes Therapeutic Diamyd is effective for at least 2 years

STOCKHOLM, Sweden, June 10, 2004 (PRIMEZONE) -- 24-month data from Diamyd Medicals (TM) Phase II clinical trial with the diabetes therapeutic Diamyd(TM) were presented today at the American Diabetes...
April 05, 2004 05:05 ET | Source: Diamyd Medical

Diamyd reports increased long-term effect in diabetes pharmaceutical and carries out guaranteed new share issue

STOCKHOLM, Sweden, April 05, 2004 (PRIMEZONE) --* 18-month data from the Phase II studies with Diamyd(TM) for the treatment of autoimmune diabetes shows that the positive effects achieved after six...
December 08, 2003 02:35 ET | Source: Diamyd Medical

Diamyd, Inc., and Diarect AG Settles Dispute

STOCKHOLM, Sweden, Dec. 08, 2003 (PRIMEZONE) -- In a press release of November 27, Diamyd Medical wrote that it "won" a dispute over Diarect, and that the judge had "decided" in favor of Diamyd. As...
November 27, 2003 04:41 ET | Source: Diamyd Medical

Diamyd, Inc. wins dispute with Diarect AG

STOCKHOLM, Sweden, Nov. 27, 2003 (PRIMEZONE) -- Diamyd Medical AB (listed on the Swedish Stock Exchange, O-list) develops a treatment for insulin dependent diabetes, Diamyd(TM). There has been an...
November 24, 2003 08:14 ET | Source: Diamyd Medical

Diamyd increases C-peptide levels in diabetes patients with GAD antibodies

STOCKHOLM, Sweden, Nov. 24, 2003 (PRIMEZONE) -- Diamyd Medical (O-list) is developing the Diamyd(TM) pharmaceutical for insulin dependent diabetes. In the Annual Report for the financial year 02/03,...
November 04, 2003 10:52 ET | Source: Diamyd Medical

Diamyd Medical: GAD2 Gene Therapy Might be used for Treatment of Anorexia

STOCKHOLM, Sweden, Nov. 4, 2003 (PRIMEZONE) -- An international research group, including among other authors Professor Philippe Froguel (Pasteur Institute, Lille, France) and Professor Ake Lernmark...
August 22, 2003 09:50 ET | Source: Diamyd Medical

Parkinson patient treated with GAD gene therapy in New York

STOCKHOLM, Sweden, August 22, 2003 (PRIMEZONE) -- Diamyd Medical (O-list) informs that Neurologix Inc has treated a first patient suffering from Parkinson's disease using GAD gene therapy. Diamyd...
June 14, 2003 11:07 ET | Source: Diamyd Medical

Diamyd reports successful clinical phase II trial with diabetes vaccine

STOCKHOLM, Sweden, June 14, 2003 (PRIMEZONE) -- Diamyd Medical AB, publicly traded on the Stockholm Stock Exchange in Sweden (O-list), today reported a positive outcome from a phase II trial with its...